Skip to Main Content

Paper Details

Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.
Nat Med
4
2022
HHF, cardiovascular, cardiovascular death, empagliflozin, glucose, heart failure, patients, sodium, sodium-glucose co-transporter 2
Author NameAffiliation
Gerasimos FilippatosNational and Kapodistrian University of Athens School of Medicine
Sergio V PerroneArgentine Catholic University
Sergio V PerroneFLENI & IADT Institute
Ileana L Pi??aCentral Michigan University
Janet SchneeBoehringer Ingelheim Pharmaceuticals Inc.
  • 1 - 5

Datasets

Release 1.2